Main description:

This new edition of an acclaimed text reviews the evidence for best practice in maternal-fetal medicine, to present the reader with the right information, with appropriate use of proven interventions and avoidance of ineffectual or harmful ones, and by rating the evidence of the key references. The information is presented in the right format by summarizing evidence succinctly and clearly in tables and algorithms. The aim is to inform the clinician, to reduce errors and "to make it easy to do it right."

The volume can be purchased separately or together with a companion volume on Obstetric Evidence Based Guidelines (set ISBN 978 1 4987 4742 4).

Contents:

Hypertensive disorders. Cardiac disease. Obesity. Pregestational diabetes. Gestational diabetes. Hypothyroidism. Hyperthyroidism. Prolactinoma. Nausea/vomiting of pregnancy and hyperemesis gravidarum. Intrahepatic cholestasis of pregnancy. Inflammatory bowel disease. Gallbladder disease. Pregnancy after liver and other transplantation. Maternal anemia. Sickle cell disease. von Willebrand disease. Renal disease. Headache. Seizures.
Spinal cord injury. Mood disorders. Smoking. Drug abuse. Respiratory diseases: asthma, pneumonia, influenza, and tuberculosis. Systemic lupus erythematosus. Antiphospholipid syndrome. Inherited thrombophilia. Venous thromboembolism and anticoagulation. Hepatitis A. Hepatitis B. Hepatitis C. HIV. Gonorrhea. Chlamydia. Syphilis. Trichomonas. Group B Streptococcus. Vaccination. Trauma. Critical care. Amniotic fluid embolism. Cancer. Dermatoses of pregnancy. Multiple gestations. Fetal growth restriction. Fetal macrosomia. Cytomegalovirus. Toxoplasmosis. Parvovirus. Herpes. Varicella. Fetal and neonatal alloimmune thrombocytopenia. Hemolytic disease of the fetus/neonate. Nonimmune hydrops fetalis. Fetal death. Antepartum testing. Sonographic assessment of amniotic fluid: oligohydramnios and polyhydramnios. Fetal maturity testing.